Press Release (ePRNews.com) - Rogers, Arkansas - Nov 07, 2016 - Highlands Oncology Group (HOG), Northwest Arkansas’ leading cancer research group, is the first cancer treatment group, globally, to open a new clinical trial which studies the use of PDL-1 immunotherapy in combination with radiation as the inaugural therapy for head and neck cancer.
“Highlands is excited to be the first institute to open this global effort to bring immunotherapy to the forefront of care for patients in our community,” Dr. J. Thaddeus Beck, of HOG, said. “This program is an extension of our phase one development.”
Cancers of the head and neck, which include cancers of the oral cavity, larynx, pharynx, salivary glands, and nose/nasal passages, account for approximately three percent of all malignancies in the United States, according to the National Cancer Institute. Tobacco and alcohol use are the most important risk factors for most head and neck cancers.
In 2016, there will be an estimated 1,685,210 new cancer cases diagnosed and 595,690 cancer deaths in the U.S., according to the American Cancer Society. As such, HOG is committed to the betterment of cancer treatment.
As the leading cancer treatment and research facility in Northwest Arkansas, Highlands Oncology Group is dedicated to the advancement of cancer treatment and to providing patients with the best possible care and results.
About Highlands Oncology Group
Highlands Oncology Group is a state-of-the-art facility, with a world-class team of specialists, that is committed to providing premier cancer treatment and to enhancing the quality of life of patients and their loved ones. Highlands Oncology group provides this in a friendly, comfortable environment conveniently located in Northwest Arkansas. Highlands offers the latest technology of diagnostic imaging and radiation therapies, on-site labs, a pharmacy and an infusion center. They also offer access to clinical trials, multidisciplinary clinics and support groups. Highlands Oncology Group is helping patients win the battle against cancer, every day!
For more information, please visit: www.HighlandsOncologyGroup.com. Source :
Highlands Oncology Group